{
 "drug": "Gadoterate Meglumine Injection",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "05/21/2026",
 "dayN": 96,
 "cat": "Medical Imaging",
 "companies": [
  "Jiangsu Hengrui Pharmaceuticals Co., Ltd."
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "06/30/2026",
   "update_type": "New",
   "initial_posting_date": "06/30/2026",
   "package_ndc": "65219-084-15",
   "generic_name": "Gadoterate Meglumine Injection",
   "contact_info": "888-386-1800",
   "related_info": "Marketed by Fresenius Kabi, USA; Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA215304"
    ],
    "brand_name": [
     "GADOTERATE MEGLUMINE"
    ],
    "generic_name": [
     "GADOTERATE MEGLUMINE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "65219-084",
     "65219-080",
     "65219-082",
     "65219-086"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "GADOTERATE MEGLUMINE"
    ],
    "spl_id": [
     "f05922b7-99d4-48c7-972a-7966bbbbc3b4"
    ],
    "spl_set_id": [
     "e0655aac-9508-4141-94f5-fcca6af1c41d"
    ],
    "package_ndc": [
     "65219-080-01",
     "65219-080-05",
     "65219-082-01",
     "65219-082-10",
     "65219-084-01",
     "65219-084-15",
     "65219-086-01",
     "65219-086-20"
    ],
    "unii": [
     "L0ND3981AG"
    ]
   },
   "update_date": "06/30/2026",
   "therapeutic_category": [
    "Medical Imaging"
   ],
   "dosage_form": "Injection",
   "presentation": "Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-084-15)",
   "company_name": "Jiangsu Hengrui Pharmaceuticals Co., Ltd.",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "06/30/2026",
   "update_type": "New",
   "initial_posting_date": "06/30/2026",
   "package_ndc": "65219-086-20",
   "generic_name": "Gadoterate Meglumine Injection",
   "contact_info": "888-386-1800",
   "related_info": "Marketed by Fresenius Kabi, USA; Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA215304"
    ],
    "brand_name": [
     "GADOTERATE MEGLUMINE"
    ],
    "generic_name": [
     "GADOTERATE MEGLUMINE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "65219-086",
     "65219-080",
     "65219-082",
     "65219-084"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "GADOTERATE MEGLUMINE"
    ],
    "spl_id": [
     "f05922b7-99d4-48c7-972a-7966bbbbc3b4"
    ],
    "spl_set_id": [
     "e0655aac-9508-4141-94f5-fcca6af1c41d"
    ],
    "package_ndc": [
     "65219-080-01",
     "65219-080-05",
     "65219-082-01",
     "65219-082-10",
     "65219-084-01",
     "65219-084-15",
     "65219-086-01",
     "65219-086-20"
    ],
    "unii": [
     "L0ND3981AG"
    ]
   },
   "update_date": "06/30/2026",
   "therapeutic_category": [
    "Medical Imaging"
   ],
   "dosage_form": "Injection",
   "presentation": "Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-086-20)",
   "company_name": "Jiangsu Hengrui Pharmaceuticals Co., Ltd.",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "06/30/2026",
   "update_type": "New",
   "initial_posting_date": "06/30/2026",
   "package_ndc": "65219-080-05",
   "generic_name": "Gadoterate Meglumine Injection",
   "contact_info": "888-386-1800",
   "related_info": "Marketed by Fresenius Kabi, USA; Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA215304"
    ],
    "brand_name": [
     "GADOTERATE MEGLUMINE"
    ],
    "generic_name": [
     "GADOTERATE MEGLUMINE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "65219-080",
     "65219-082",
     "65219-084",
     "65219-086"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "GADOTERATE MEGLUMINE"
    ],
    "spl_id": [
     "f05922b7-99d4-48c7-972a-7966bbbbc3b4"
    ],
    "spl_set_id": [
     "e0655aac-9508-4141-94f5-fcca6af1c41d"
    ],
    "package_ndc": [
     "65219-080-01",
     "65219-080-05",
     "65219-082-01",
     "65219-082-10",
     "65219-084-01",
     "65219-084-15",
     "65219-086-01",
     "65219-086-20"
    ],
    "unii": [
     "L0ND3981AG"
    ]
   },
   "update_date": "06/30/2026",
   "therapeutic_category": [
    "Medical Imaging"
   ],
   "dosage_form": "Injection",
   "presentation": "Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-080-05)",
   "company_name": "Jiangsu Hengrui Pharmaceuticals Co., Ltd.",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "05/21/2026",
   "update_type": "New",
   "initial_posting_date": "05/21/2026",
   "package_ndc": "65219-080-05",
   "generic_name": "Gadoterate Meglumine Injection",
   "contact_info": "Marketed by Fresenius Kabi, USA; Customer service: 888-386-1300",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA215304"
    ],
    "brand_name": [
     "GADOTERATE MEGLUMINE"
    ],
    "generic_name": [
     "GADOTERATE MEGLUMINE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "65219-080",
     "65219-082",
     "65219-084",
     "65219-086"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "GADOTERATE MEGLUMINE"
    ],
    "spl_id": [
     "f05922b7-99d4-48c7-972a-7966bbbbc3b4"
    ],
    "spl_set_id": [
     "e0655aac-9508-4141-94f5-fcca6af1c41d"
    ],
    "package_ndc": [
     "65219-080-01",
     "65219-080-05",
     "65219-082-01",
     "65219-082-10",
     "65219-084-01",
     "65219-084-15",
     "65219-086-01",
     "65219-086-20"
    ],
    "unii": [
     "L0ND3981AG"
    ]
   },
   "update_date": "05/21/2026",
   "therapeutic_category": [
    "Medical Imaging"
   ],
   "dosage_form": "Injection",
   "presentation": "Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-080-05)",
   "company_name": "Jiangsu Hengrui Pharmaceuticals Co., Ltd.",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "05/21/2026",
   "update_type": "New",
   "initial_posting_date": "05/21/2026",
   "package_ndc": "65219-084-15",
   "generic_name": "Gadoterate Meglumine Injection",
   "contact_info": "Marketed by Fresenius Kabi, USA; Customer service: 888-386-1300",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA215304"
    ],
    "brand_name": [
     "GADOTERATE MEGLUMINE"
    ],
    "generic_name": [
     "GADOTERATE MEGLUMINE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "65219-084",
     "65219-080",
     "65219-082",
     "65219-086"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "GADOTERATE MEGLUMINE"
    ],
    "spl_id": [
     "f05922b7-99d4-48c7-972a-7966bbbbc3b4"
    ],
    "spl_set_id": [
     "e0655aac-9508-4141-94f5-fcca6af1c41d"
    ],
    "package_ndc": [
     "65219-080-01",
     "65219-080-05",
     "65219-082-01",
     "65219-082-10",
     "65219-084-01",
     "65219-084-15",
     "65219-086-01",
     "65219-086-20"
    ],
    "unii": [
     "L0ND3981AG"
    ]
   },
   "update_date": "05/21/2026",
   "therapeutic_category": [
    "Medical Imaging"
   ],
   "dosage_form": "Injection",
   "presentation": "Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-084-15)",
   "company_name": "Jiangsu Hengrui Pharmaceuticals Co., Ltd.",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "06/30/2026",
   "update_type": "New",
   "initial_posting_date": "06/30/2026",
   "package_ndc": "65219-082-10",
   "generic_name": "Gadoterate Meglumine Injection",
   "contact_info": "888-386-1800",
   "related_info": "Marketed by Fresenius Kabi, USA; Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA215304"
    ],
    "brand_name": [
     "GADOTERATE MEGLUMINE"
    ],
    "generic_name": [
     "GADOTERATE MEGLUMINE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "65219-082",
     "65219-080",
     "65219-084",
     "65219-086"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "GADOTERATE MEGLUMINE"
    ],
    "spl_id": [
     "f05922b7-99d4-48c7-972a-7966bbbbc3b4"
    ],
    "spl_set_id": [
     "e0655aac-9508-4141-94f5-fcca6af1c41d"
    ],
    "package_ndc": [
     "65219-080-01",
     "65219-080-05",
     "65219-082-01",
     "65219-082-10",
     "65219-084-01",
     "65219-084-15",
     "65219-086-01",
     "65219-086-20"
    ],
    "unii": [
     "L0ND3981AG"
    ]
   },
   "update_date": "06/30/2026",
   "therapeutic_category": [
    "Medical Imaging"
   ],
   "dosage_form": "Injection",
   "presentation": "Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-082-10)",
   "company_name": "Jiangsu Hengrui Pharmaceuticals Co., Ltd.",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "05/21/2026",
   "update_type": "New",
   "initial_posting_date": "05/21/2026",
   "package_ndc": "65219-082-10",
   "generic_name": "Gadoterate Meglumine Injection",
   "contact_info": "Marketed by Fresenius Kabi, USA; Customer service: 888-386-1300",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA215304"
    ],
    "brand_name": [
     "GADOTERATE MEGLUMINE"
    ],
    "generic_name": [
     "GADOTERATE MEGLUMINE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "65219-082",
     "65219-080",
     "65219-084",
     "65219-086"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "GADOTERATE MEGLUMINE"
    ],
    "spl_id": [
     "f05922b7-99d4-48c7-972a-7966bbbbc3b4"
    ],
    "spl_set_id": [
     "e0655aac-9508-4141-94f5-fcca6af1c41d"
    ],
    "package_ndc": [
     "65219-080-01",
     "65219-080-05",
     "65219-082-01",
     "65219-082-10",
     "65219-084-01",
     "65219-084-15",
     "65219-086-01",
     "65219-086-20"
    ],
    "unii": [
     "L0ND3981AG"
    ]
   },
   "update_date": "05/21/2026",
   "therapeutic_category": [
    "Medical Imaging"
   ],
   "dosage_form": "Injection",
   "presentation": "Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-082-10)",
   "company_name": "Jiangsu Hengrui Pharmaceuticals Co., Ltd.",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "05/21/2026",
   "update_type": "New",
   "initial_posting_date": "05/21/2026",
   "package_ndc": "65219-086-20",
   "generic_name": "Gadoterate Meglumine Injection",
   "contact_info": "Marketed by Fresenius Kabi, USA; Customer service: 888-386-1300",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA215304"
    ],
    "brand_name": [
     "GADOTERATE MEGLUMINE"
    ],
    "generic_name": [
     "GADOTERATE MEGLUMINE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "65219-086",
     "65219-080",
     "65219-082",
     "65219-084"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "GADOTERATE MEGLUMINE"
    ],
    "spl_id": [
     "f05922b7-99d4-48c7-972a-7966bbbbc3b4"
    ],
    "spl_set_id": [
     "e0655aac-9508-4141-94f5-fcca6af1c41d"
    ],
    "package_ndc": [
     "65219-080-01",
     "65219-080-05",
     "65219-082-01",
     "65219-082-10",
     "65219-084-01",
     "65219-084-15",
     "65219-086-01",
     "65219-086-20"
    ],
    "unii": [
     "L0ND3981AG"
    ]
   },
   "update_date": "05/21/2026",
   "therapeutic_category": [
    "Medical Imaging"
   ],
   "dosage_form": "Injection",
   "presentation": "Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-086-20)",
   "company_name": "Jiangsu Hengrui Pharmaceuticals Co., Ltd.",
   "status": "To Be Discontinued"
  }
 ]
}